Are toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes?

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Sireci, Guido ^a   Guggino, Giuliana ^a   Giardina, Anna Rita ^a   Ciccia, Francesco ^a   Triolo, Giovanni ^a   Dieli, Francesco ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA INTERFERON; CCL14 CHEMOKINE; DECOY RECEPTOR 3; EOTAXIN; GAMMA INTERFERON; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MYELOID DIFFERENTIATION FACTOR 88; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR DECOY RECEPTOR; UNCLASSIFIED DRUG; AUTOANTIGEN; CHEMOKINE;

APOPTOSIS; AUTOIMMUNITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LUPUS LIKE SYNDROME; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL COMMUNICATION; DISEASE MODEL; IMMUNOLOGY; INNATE IMMUNITY; MOUSE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CELL COMMUNICATION; CHEMOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR DECOY RECEPTORS;

EID: 80053550874     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/135932     Document Type: Review

References (34)

1. Gualtierotti R., Biggioggero M., Penatti A. E., Meroni P. L., Updating on the pathogenesis of systemic lupus erythematosus Autoimmunity Reviews 2010 10 1 3 7
2. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity Cell 2006 124 4 783 801 (Pubitemid 43261452)
3. Richez C., Blanco P., Rifkin I., Moreau J. F., Schaeverbeke T., Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus Joint Bone Spine 2011 78 2 124 130
4. Radstake T. R., Roelofs M. F., Jenniskens Y. M., Oppers-Walgreen B., Van Riel P. L., Barrera P., Joosten L. A., Van Den Berg W. B., Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon- Arthritis and Rheumatism 2004 50 12 3856 3865 (Pubitemid 39643932)
5. Seibl R., Birchler T., Loeliger S., Hossle J. P., Gay R. E., Saurenmann T., Michel B. A., Seger R. A., Gay S., Lauener R. P., Expression and regulation of toll-like receptor 2 in rheumatoid arthritis synovium American Journal of Pathology 2003 162 4 1221 1227 (Pubitemid 36350666)
6. Sadanaga A., Nakashima H., Akahoshi M., Masutani K., Miyake K., Igawa T., Sugiyama N., Niiro H., Harada M., Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice Arthritis and Rheumatism 2007 56 5 1618 1628 (Pubitemid 46764091)
7. Herrmann M., Voll R. E., Zoller O. M., Hagenhofer M., Ponner B. B., Kalden J. R., Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus Arthritis and Rheumatism 1998 41 7 1241 1250 (Pubitemid 28313427)
8. Wermeling F., Lind S. M., Jord E. D., Cardell S. L., Karlsson M. C., Invariant NKT cells limit activation of autoreactive CD1d-positive B cells Journal of Experimental Medicine 2010 207 5 943 952
9. Green D. R., Ferguson T., Zitvogel L., Kroemer G., Immunogenic and tolerogenic cell death Nature Reviews Immunology 2009 9 5 353 363
10. Utz P. J., Gensler T. J., Anderson P., Death, autoantigen modifications, and tolerance Arthritis Research 2000 2 2 101 114 (Pubitemid 32223707)
11. Gaipl U. S., Kuhn A., Sheriff A., Munoz L. E., Franz S., Voll R. E., Kalden J. R., Herrmann M., Clearance of apoptotic cells in human SLE Current Directions in Autoimmunity. 2006 9 173 187
12. Treml L. S., Carlesso G., Hoek K. L., Stadanlick J. E., Kambayashi T., Bram R. J., Cancro M. P., Khan W. N., TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells Journal of Immunology 2007 178 12 7531 7539 (Pubitemid 46898021)
13. Liu Z., Davidson A., BAFF inhibition: a new class of drugs for the treatment of autoimmunity Experimental Cell Research 2011 317 9 1270 1277
14. Groom J. R., Fletcher C. A., Walters S. N., Grey S. T., Watt S. V., Sweet M. J., Smyth M. J., Mackay C. R., Mackay F., BAFF and MyD88 signals promote a lupuslike disease independent of T cells Journal of Experimental Medicine 2007 204 8 1959 1971 (Pubitemid 47236330)
15. Horton C. G., Pan Z. J., Farris A. D., Targeting toll-like receptors for treatment of SLE Mediators of Inflammation 2010 2010 9
16. Lafyatis R., Marshak-Rothstein A., Toll-like receptors and innate immune responses in systemic lupus erythematosus Arthritis Research and Therapy 2007 9 6, article 222
17. Pawar R. D., Ramanjaneyulu A., Kulkarni O. P., Lech M., Segerer S., Anders H. J., Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus Journal of the American Society of Nephrology 2007 18 6 1721 1731 (Pubitemid 46870309)
18. Hackl D., Loschko J., Sparwasser T., Reindl W., Krug A. B., Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs European Journal of Immunology 2011 41 5 1334 1343
19. Christensen S. R., Shupe J., Nickerson K., Kashgarian M., Flavell R. A., Shlomchik M. J., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus Immunity 2006 25 3 417 428 (Pubitemid 44354217)
20. Bratke K., Klein C., Kuepper M., Lommatzsch M., Virchow J. C., Differential development of plasmacytoid dendritic cells in Th1- and Th2-like cytokine milieus Allergy 2011 66 3 386 395
21. Tournadre A., Lenief V., Miossec P., Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines Arthritis and Rheumatism 2010 62 7 2144 2151
22. Lombardi V., Van Overtvelt L., Horiot S., Moingeon P., Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-, and IL-17A by naive CD4 + T cells Journal of Immunology 2009 182 6 3372 3379
23. Yates J., Whittington A., Mitchell P., Lechler R. I., Lightstone L., Lombardi G., Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis Clinical and Experimental Immunology 2008 153 1 44 55 (Pubitemid 351809334)
24. Bovenschen H. J., van de Kerkhof P. C., van Erp P. E., Woestenenk R., Joosten I., Koenen H. J., Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. Journal of Investigative Dermatology. In press
25. Liu B., Yang Y., Dai J., Medzhitov R., Freudenberg M. A., Zhang P. L., Li Z., TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease Journal of Immunology 2006 177 10 6880 6888 (Pubitemid 44715053)
26. Lee T. P., Tang S. J., Wu M. F., Song Y. C., Yu C. L., Sun K. H., Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes Journal of Autoimmunity 2010 35 4 358 367
27. Rahman A. H., Eisenberg R. A., The role of Toll-like receptors in systemic lupus erythematosus Springer Seminars in Immunopathology 2006 28 2 131 143 (Pubitemid 46628482)
28. Di Liberto D., Caccamo N., Meraviglia S., Guggino G., La Manna M. P., Sireci G., Salerno A., Dieli F., Tuning inflammation in tuberculosis: the role of decoy receptors Microbes and Infection 2009 11 10-11 821 827
29. Mantovani A., Locati M., Vecchi A., Sozzani S., Allavena P., Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines Trends in Immunology 2001 22 6 328 336 (Pubitemid 32675247)
30. Han B., Moore P. A., Wu J., Luo H., Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome Arthritis and Rheumatism 2007 56 11 3748 3758 (Pubitemid 350100708)
31. Hayakawa K., Hardy R. R., Herzenberg L. A., Progenitors for Ly-1 B cells are distinct from progenitors for other B cells Journal of Experimental Medicine 1985 161 6 1554 1568 (Pubitemid 15046047)
32. Wan X., Shi G., Semenuk M., Zhang J., Wu J., DcR3/TR6 modulates immune cell interactions Journal of Cellular Biochemistry 2003 89 3 603 612 (Pubitemid 36648781)
33. Wu Y., Han B., Sheng H., Lin M., Moore P. A., Zhang J., Wu J., Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients International Journal of Cancer 2003 105 5 724 732 (Pubitemid 36687744)
34. Di Liberto D., Locati M., Caccamo N., Vecchi A., Meraviglia S., Salerno A., Sireci G., Nebuloni M., Caceres N., Cardona P. J., Dieli F., Mantovani A., Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection Journal of Experimental Medicine 2008 205 9 2075 2084